|Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy|
D Finzi, M Hermankova, T Pierson, LM Carruth, C Buck, RE Chaisson, ...
Science 278 (5341), 1295-1300, 1997
|Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy|
D Finzi, J Blankson, JD Siliciano, JB Margolick, K Chadwick, T Pierson, ...
Nature medicine 5 (5), 512-517, 1999
|Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection|
TW Chun, L Carruth, D Finzi, X Shen, JA DiGiuseppe, H Taylor, ...
Nature 387 (6629), 183-188, 1997
|Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells|
JD Siliciano, J Kajdas, D Finzi, TC Quinn, K Chadwick, JB Margolick, ...
Nature medicine 9 (6), 727-728, 2003
|Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure|
YC Ho, L Shan, NN Hosmane, J Wang, SB Laskey, DIS Rosenbloom, ...
Cell 155 (3), 540-551, 2013
|The challenge of viral reservoirs in HIV-1 infection|
JN Blankson, D Persaud, RF Siliciano
Annual review of medicine 53 (1), 557-593, 2002
|In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency|
TW Chun, D Finzi, J Margolick, K Chadwick, D Schwartz, RF Siliciano
Nature medicine 1 (12), 1284-1290, 1995
|Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation|
L Shan, K Deng, NS Shroff, CM Durand, SA Rabi, HC Yang, H Zhang, ...
Immunity 36 (3), 491-501, 2012
|Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy|
T Pierson, J McArthur, RF Siliciano
Annual review of immunology 18 (1), 665-708, 2000
|A soluble CD4 protein selectively inhibits HIV replication and syncytium formation|
RE Hussey, NE Richardson, M Kowalski, NR Brown, HC Chang, ...
Nature 331 (6151), 78-81, 1988
|Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy|
JB Dinoso, SY Kim, AM Wiegand, SE Palmer, SJ Gange, L Cranmer, ...
Proceedings of the National Academy of Sciences 106 (23), 9403-9408, 2009
RF Siliciano, WC Greene
Cold Spring Harbor perspectives in medicine 1 (1), a007096, 2011
|Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies|
S Eriksson, EH Graf, V Dahl, MC Strain, SA Yukl, ES Lysenko, RJ Bosch, ...
PLoS pathogens 9 (2), 2013
|Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion|
RF Siliciano, T Lawton, C Knall, RW Karr, P Berman, T Gregory, ...
Cell 54 (4), 561-575, 1988
|Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART|
RE Nettles, TL Kieffer, P Kwon, D Monie, Y Han, T Parsons, ...
Jama 293 (7), 817-829, 2005
|Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating …|
JR Bailey, AR Sedaghat, T Kieffer, T Brennan, PK Lee, M Wind-Rotolo, ...
Journal of virology 80 (13), 6441-6457, 2006
|Control of HIV despite the discontinuation of antiretroviral therapy|
J Lisziewicz, E Rosenberg, J Lieberman, H Jessen, L Lopalco, R Siliciano, ...
New England Journal of Medicine 340 (21), 1683-1683, 1999
|Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations|
K Deng, M Pertea, A Rongvaux, L Wang, CM Durand, G Ghiaur, J Lai, ...
Nature 517 (7534), 381-385, 2015
|New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo|
CK Bullen, GM Laird, CM Durand, JD Siliciano, RF Siliciano
Nature medicine 20 (4), 425, 2014
|Redefining the viral reservoirs that prevent HIV-1 eradication|
E Eisele, RF Siliciano
Immunity 37 (3), 377-388, 2012